Zinc Transporters in Prostate Cancer
Author Information
Author(s): Desouki Mohamed M, Geradts Joseph, Milon Beatrice, Franklin Renty B, Costello Leslie C
Primary Institution: Medical University of South Carolina
Hypothesis
The study investigates the expression of Zip2 and Zip3 zinc transporters in malignant versus nonmalignant prostate glands.
Conclusion
Zip2 and Zip3 are down regulated in malignant prostate cells, which contributes to the loss of zinc accumulation associated with prostate cancer.
Supporting Evidence
- Normal and BPH glands showed strong presence of Zip2 and Zip3, while malignant glands had negligible levels.
- The study is the first to report the expression of Zip3 in human prostate tissue.
- Both Zip2 and Zip3 are localized at the apical cell membrane, unlike Zip1 which is at the basolateral membrane.
Takeaway
This study found that two proteins that help prostate cells keep zinc are missing in cancerous cells, which might help explain why cancer cells can't hold onto zinc.
Methodology
Immunohistochemistry analysis of human prostate tissue sections was performed to determine the expression levels of Zip2 and Zip3.
Limitations
The study does not provide information on the expression of these transporters in metastatic cells.
Participant Demographics
The study included 25 cases of prostatic adenocarcinoma, with some cases also showing normal prostatic acini.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website